The etiopathogenesis of ulcerative colitis and its management by Ayurvedic treatment

The requested reference [c5c0e30152fcbf19fd255d59b76951e9c509f5f7] no longer exists in our database. It has been replaced by the current reference: [d113f34e5185113433e6b90c3841312609506add]

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2021
INTERVENTION: Intervention1: NIL: NIL Intervention2: Nilotapaldi Yoga in Oral Form and Piccha basti.: Group B ‐ These patients will be treated with‐ 1. Nilotpaladi Yoga (Ca. Ch. 19 75) Nilakamala (Nymphaea nouchali Burm. f.)‐ 750 mg Mocharasa (Salmalia malabarica Schott and Endl.)‐ 750 mg Lajavanti (Mimosa pudica Linn.)‐750 mg Kamalakesara (Nelumbo nucifera Gaertn.)‐ 750 mg The powder of above ingredients will be given 3 gms twice daily orally with goat milk followed by intake of rice. 2. A. Piccha basti ingredients (Ca. Ch. 19 63‐66) Goat Milk‐ 1 Prastha (640gms) Mocharasa (Salmalia malabarica Schott and Endl.) v.‐ 1 Musti (40 gms) (Pala) Paste of Yasthimadhu (Glycyrrhiza glabra Linn)‐40 gms as per requirement Ghee and Taila‐ in such quantities by which the liquid becomes unctuous (Sneha) Piccha Basti will be given after dinner as per standard method. Control Intervention1: Study on the etiopathogenesis of ulcerative colitis and its management by Ayurvedic formulation: Group B ‐ These patients will be treated with‐ 1. Nilotpaladi Yoga (Ca. Ch. Atisara Chikitsa) Nilakamala (Nymphaea nouchali Burm. f.)‐ 750 mg Mocharasa (Salmalia malabarica Schott and Endl.)‐ 750 mg Lajavanti (Mimosa pudica Linn.)‐750 mg Kamalakesara (Nelumbo nucifera Gaertn.)‐ 750 mg The powder of above ingredients will be given 3 gms twice daily orally with goat milk followed by intake of rice. 2. A. Piccha basti ingredients (Ca. Ch. Atisara Chikitsa) Goat Milk‐ 1 Prastha (640gms) Mocharasa (Salmalia malabarica Schott and Endl.) v.‐ 1 Musti 40 gms, 1 Pala Paste of Yasthimadhu Glycyrrhiza glabra Linn. 40 gms as per requirement Ghee and Taila, in such quantities b CONDITION: Health Condition 1: K922‐ Gastrointestinal hemorrhage, unspecified PRIMARY OUTCOME: 50 patientsTimepoint: 4 weeks SECONDARY OUTCOME: NILTimepoint: NIL INCLUSION CRITERIA: INCLUSION CRITERIA: Mild to moderate type (Mayo score 3‐10) of Ulcerative colitis patients irrespective of age and sex
Epistemonikos ID: 35c0e58b9fa19c350c81e94832890648f8fa92b2
First added on: Mar 23, 2022